Trumpâs Pfizer deal will increase drug costs
From our US edition
President Donald Trumpâs new partnership with Pfizer to sell drugs directly to consumers is being cast as a major win for patients. Heâs right about the problem: healthcare and prescription drugs cost too much. Families are struggling, and patients often face heartbreaking choices between groceries, rent and the medicines they need. But the proposed solution isnât tackling the root of the issue. It risks exacerbating federal government failures that created this problem.For starters, Pfizer is claiming that this new campaign is about lowering consumer costs. But itâs really about creating a cozy relationship with the government that nobody else can.